Omni Bio Pharmaceutical Inc logo

OMBP - Omni Bio Pharmaceutical Inc Share Price

$0 0.0  0.0%

Last Trade - 26/05/20

Sector
Healthcare
Size
Micro Cap
Market Cap £13.0k
Enterprise Value £1.56m
Revenue £n/a
Position in Universe th / 6317
Bullish
Bearish
Unlock OMBP Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the nine months ended 31 December 2014, Omni Bio Pharmaceutical Inc revenues was not reported. Net loss increased 55% to $3.2M. Higher net loss reflects Amortization of debt discount - related increase from $132K to $745K (expense), Research and development increase from $163K to $471K (expense), G/L on Invest. HFS, Maturity & Tradi decrease from $22K (income) to $274K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OMBP Revenue Unlock OMBP Revenue

Net Income

OMBP Net Income Unlock OMBP Revenue

Normalised EPS

OMBP Normalised EPS Unlock OMBP Revenue

PE Ratio Range

OMBP PE Ratio Range Unlock OMBP Revenue

Dividend Yield Range

OMBP Dividend Yield Range Unlock OMBP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OMBP EPS Forecasts Unlock OMBP Revenue
Profile Summary

Omni Bio Pharmaceutical, Inc. is a biopharmaceutical company. The Company is focused on exploring methods of use of alpha-1 antitrypsin (AAT), also referred to as plasma-derived AAT (p-AAT). AAT is a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood (p-AAT) to treat patients suffering from emphysema due to AAT-deficiency. AAT is purified from human blood and has found to have significant anti-inflammatory, immunomodulatory and tissue protective effects in various animal models of human disease. The Company's clinical data have emerged showing p-AAT's potential utility in the treatment of Type 1 diabetes, post-myocardial infarction heart disease and Graft versus Host Disease (GvHD). The Company's focus on research and development efforts is advancing its first recombinant molecule, AAT and an Fc component of immunoglobulin (AAT-Fc 2) into clinical trials.

Directors
Last Annual March 31st, 2014
Last Interim December 31st, 2014
Incorporated December 1, 2005
Public Since June 13, 1996
No. of Shareholders: 431
No. of Employees: 1
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OTC Markets Group
Shares in Issue 40,462,602
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OMBP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OMBP
Upcoming Events for OMBP
Frequently Asked Questions for Omni Bio Pharmaceutical Inc
What is the Omni Bio Pharmaceutical Inc share price?

As of 26/05/20, shares in Omni Bio Pharmaceutical Inc are trading at $0, giving the company a market capitalisation of £13.0k. This share price information is delayed by 15 minutes.

How has the Omni Bio Pharmaceutical Inc share price performed this year?

Shares in Omni Bio Pharmaceutical Inc are currently trading at $0 and the price has moved by -96% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Omni Bio Pharmaceutical Inc price has moved by -96.1% over the past year.

What are the analyst and broker recommendations for Omni Bio Pharmaceutical Inc?

Of the analysts with advisory recommendations for Omni Bio Pharmaceutical Inc, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Omni Bio Pharmaceutical Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Omni Bio Pharmaceutical Inc next release its financial results?

Omni Bio Pharmaceutical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2015-12-31
What is the Omni Bio Pharmaceutical Inc dividend yield?

Omni Bio Pharmaceutical Inc does not currently pay a dividend.

Does Omni Bio Pharmaceutical Inc pay a dividend?

Omni Bio Pharmaceutical Inc does not currently pay a dividend.

When does Omni Bio Pharmaceutical Inc next pay dividends?

Omni Bio Pharmaceutical Inc does not currently pay a dividend.

How do I buy Omni Bio Pharmaceutical Inc shares?

To buy shares in Omni Bio Pharmaceutical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Omni Bio Pharmaceutical Inc?

Shares in Omni Bio Pharmaceutical Inc are currently trading at $0, giving the company a market capitalisation of £13.0k.

Where are Omni Bio Pharmaceutical Inc shares listed? Where are Omni Bio Pharmaceutical Inc shares listed?

Here are the trading details for Omni Bio Pharmaceutical Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: OMBP
What kind of share is Omni Bio Pharmaceutical Inc?

We were not able to load our ranking data for Omni Bio Pharmaceutical Inc

Is there a Omni Bio Pharmaceutical Inc share price forecast 2020?

We were not able to load any forecast data for Omni Bio Pharmaceutical Inc.

How can I tell whether the Omni Bio Pharmaceutical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Omni Bio Pharmaceutical Inc. Over the past six months, the relative strength of its shares against the market has been 43.38%. At the current price of $0, shares in Omni Bio Pharmaceutical Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Omni Bio Pharmaceutical Inc PE Ratio?

We were not able to find PE ratio data for Omni Bio Pharmaceutical Inc.

Who are the key directors of Omni Bio Pharmaceutical Inc?

Omni Bio Pharmaceutical Inc's management team is headed by:

Bruce Schneider - CFO
John Riccardi - DRC
Bruce Forrest - OTH
Who are the major shareholders of Omni Bio Pharmaceutical Inc?

Here are the top five shareholders of Omni Bio Pharmaceutical Inc based on the size of their shareholding:

Similar to OMBP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.